The Body Covers: The XV International AIDS Conference
Complete Index
Enfuvirtide Benefits Persist for at Least 2 Years (Oral MoOrB1058)Calvin J. Cohen, M.D., M.S.
More Data on Higher-Dose Lopinavir/Ritonavir (Poster TuPeB4555)Paul E. Sax, M.D.
Five Days On, 2 Days Off: A Pilot Study on Innovative Treatment of HIV Infection (Poster TuPeB4575)Gerald Pierone Jr., M.D.
Tenofovir and Abacavir Do Not Interact in Patients on Triple-Nucleoside Regimens (Poster TuPeB4627)Calvin J. Cohen, M.D., M.S.
Failure of Tenofovir/Abacavir/Lamivudine Combination Still Unexplained (Poster TuPeB4629)Mark Holodniy, M.D., F.A.C.P., C.I.C.
Fosamprenavir Update (Oral MoOrB1055, Poster TuPeB4504, Poster TuPeB4506, Poster TuPeB4507)Benjamin Young, M.D., Ph.D.
Most Common Regimens Used in San Francisco Yield Equal Chances of Survival (Oral MoOrC1082)Frank S. Rhame, M.D.
Update on Long-Term Follow-Up Studies on Tenofovir (Oral MoOrB1083, Poster TuPeB4538, Poster WePeB5757, Poster WePeB5917)Benjamin Young, M.D., Ph.D.
Data on HIV Disease Prognosis 5 Years After Initiating HAART (Oral TuOrC1157)Thanes J. Vanig, M.D.
Confort Study Supports Switch From Protease Inhibitor to Nevirapine (Oral WeOrB1287)Frank S. Rhame, M.D.
Zidovudine/Lamivudine/Abacavir May Be Effective Alone for Induction Maintenance (Oral LbOrB14)Frank S. Rhame, M.D.
Negative HIV Antibody Test Results Among People Treated During Acute/Early Infection (Poster MoPeB3107)David A. Wohl, M.D.
Patients Beginning HAART With a Low CD4+ Cell Count Respond Well (Poster MoPeB3356)Thanes J. Vanig, M.D.
HIV Infection and Antiretroviral Therapy in Patients Over 50 (Poster MoPeB3366)Thanes J. Vanig, M.D.
Lamivudine/Abacavir Is an Effective Nucleoside Backbone in Combinations Other Than With Tenofovir (Poster TuPeB4502)Frank S. Rhame, M.D.
Update on the Safety and Efficacy of Abacavir (Poster TuPeB4521, Poster WePeB5698, Poster WePeB5868)Benjamin Young, M.D., Ph.D.
A Head-to-Head Comparison of Initial HIV Treatment With PI-, NNRTI- or NRTI-Based Regimens (Poster TuPeB4544, Poster WePeB5944)David A. Wohl, M.D.
Drug Switching Can Resensitize Patients With Multidrug-Resistant HIV-1 (Poster TuPeB4556)Mark Holodniy, M.D., F.A.C.P., C.I.C.
Treatment of HIV Infection With Prednisolone (Poster TuPeB4582)Gerald Pierone Jr., M.D.
Metabolic Complications of HIV and Its Therapies (Oral MoOrB1060, Oral MoOrB1083, Poster TuPeB4577, Poster TuPeB4595, Poster WePeB5874, Poster WePeB5925, Poster WePeB5964)David A. Wohl, M.D.
Are Protease Inhibitors More Likely to Cause Atherosclerosis Than NNRTIs? (Oral ThOrB1355)Thanes J. Vanig, M.D.
HAART Reduces Incidence and Improves Long-Term Prognosis of Non-Hodgkin's Lymphoma (Oral ThOrB1403)Frank S. Rhame, M.D.
HDL Benefit Is Maintained With Extension of Nevirapine and Efavirenz Treatment in 2NN Study (Poster WePpB2065)Gerald Pierone Jr., M.D.
Anal Cancer Still a Risk to HIV-Infected Men Who Have Receptive Anal Intercourse (Poster MoPeB3251)Frank S. Rhame, M.D.
Non-Hodgkin's Lymphoma Rates Lower in HAART-Treated Patients (Poster MoPeB3257)Frank S. Rhame, M.D.
Aging HIV-Infected Population at Risk for Malignancies Despite HAART (Poster MoPeB3264)Frank S. Rhame, M.D.
Response to Lopinavir/Ritonavir in HIV-Infected Patients Coinfected With Hepatitis C and/or Hepatitis B (Poster MoPeB3285)Paul E. Sax, M.D.
Both Tenofovir and Stavudine Well Tolerated in HCV-Coinfected Patients (Poster MoPeB3307)Paul E. Sax, M.D.
HBV Infection: Two Drugs Are Better Than One (Poster MoPeB3308)Paul E. Sax, M.D.
A HAART Regimen With Lower Metabolic Effect (Poster WePeB5865)Margaret Hoffman-Terry, M.D., F.A.C.P.
Substituting With Tenofovir Decreases the Adverse Effects Seen With Other NRTIs (Poster WePeB5880)Calvin J. Cohen, M.D., M.S.
Hypertriglyceridemic Patients on HAART Have Increased Risk of Cardiovascular Disease (Poster WePeB5902)Thanes J. Vanig, M.D.
Bone Cement Injections Show Success as Facial Wasting Treatment (July 16, 2004)
HIV Prevention Programs for Teens Must Deal With Sexuality, Youth Speakers Say (July 15, 2004)
Cambodian Sex Workers Protest Study on Use of Tenofovir to Prevent HIV (July 15, 2004)
HIV Prevention Programs Must Target Displaced Populations, Experts Say (July 15, 2004)
Voucher Program for Injection Drug Users in Asia Reduces HIV Incidence (July 15, 2004)
Discrimination, Gender Inequality Challenge HIV Prevention Efforts in South Asia (July 15, 2004)
Microbicide Trials to Be Aimed at Women Due to Growing HIV/AIDS Impact on Female Population (July 14, 2004)
Emphasis on Ethnic Pride, Communication Reduces HIV Risk Behavior Among African-American Girls (July 13, 2004)
Ugandan President Stirs Controversy for Downplaying Use of Condoms to Prevent HIV (July 12, 2004)
HIV Vaccine Research Funding Is Far Below Needed Level, Vaccine Initiative's Report Says (July 12, 2004)
Governments That Bar Injection Drug Users From Treatment Fuel Spread of HIV, WHO Says (July 19, 2004)
U.K. Rejects U.S. Policies on HIV Prevention, Generic Antiretrovirals (July 16, 2004)
Researchers Unveil Portable, Battery-Powered CD4 Monitoring Device (July 15, 2004)
Antiretroviral Doses, Treatment Tools Ignore Needs of Children, Medical Group Says (July 15, 2004)
Generic Fixed-Dose Combination Drugs Succeed in First Large-Scale Study (July 15, 2004)
Widespread Nevirapine Resistance May Threaten Asia Due to Poor Adherence, Treatment Monitoring (July 15, 2004)
Interview With Ambassador Randall Tobias (July 14, 2004)
Médecins Sans Frontières Presents Data Showing Antiretroviral Therapy Can Improve Survival in Developing Countries (July 14, 2004)
U.S. Global AIDS Coordinator Tobias Addresses XV International AIDS Conference; Speech Interrupted by Protesters (July 14, 2004)
Disagreement, Poor Coordination Among Donors Hinder Global AIDS Fight, Experts Say (July 13, 2004)
Half of Global Fund Grant Recipients Performing Well, Report Says (July 13, 2004)
Protesters, Targeting Drug Companies, Disrupt More Events at AIDS 2004 (July 13, 2004)
Funding the Response to HIV/AIDS: Why Are Donors Not Working Together? (July 12, 2004)PDF , RealPlayer video and Windows Media video
HIV Treatment Access Protesters Make Their Presence Felt at AIDS 2004 (July 12, 2004)
U.S. Official Defends Global AIDS Initiative Amidst Protests at AIDS 2004 (July 12, 2004)
HIV Treatment Programs in India, South Africa, Thailand Discussed at AIDS 2004 (July 12, 2004)
AIDS 2004 Satellite Meeting Assesses Slow Advance of Global Treatment Access (July 12, 2004)
Thai Prime Minister Pledges HIV Treatment for All Citizens, but Advocates Are Skeptical (July 12, 2004)
Advertisement
